Private company
Chione Ltd
Last updated Oct 21, 2026.
Overview
- HeadquartersG41
Corporate structure
Chione Ltd sits at the top of its group. 4 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- Chione Ltd G4
- Acrivon Therapeutics, Inc. Stake · Watertown, Massachusetts
- Karyopharm Therapeutics Inc. Stake · Wilmington, Delaware, United States
- SERA PROGNOSTICS, INC. Stake · Salt Lake City, Utah
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (3 companies). Each entity in the chart links to its source.
Stakes it holds
Chione Ltd has told the SEC it owns more than 5% of 3 companies, latest first (Schedules 13D and 13G).
- SERA PROGNOSTICS, INC.SCHEDULE 13D/A Feb 14, 20252
- Acrivon Therapeutics, Inc.SC 13G/A Nov 28, 2022 to Jul 10, 20243
- Karyopharm Therapeutics Inc.SC 13G/A Feb 11, 2022 to Feb 14, 20234
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARChione Ltd filings on SEC EDGAR
- 2
- 3
- 4